Effects of intermittent and long-term Glucose-insulin-potassium infusion in patients with systolic heart failure

Experimental and Clinical Cardiology

Volumn 13, Issue 2, 2008, Pages 85-88

  Kalay, Nihat ^a   Ozdogru, Ibrahim ^b   Gul, Ali ^b   Yucel, Yilmaz ^b   Cetinkaya, Yakup ^c   Inanc, Mehmet Tugrul ^b   Dogan, Ali ^b   Kaya, Mehmet Gungor ^b   Eryol, Namik Kemal ^b  

^a Sorgun Devlet Hastanesi   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c Department of Cardiology   (Turkey)

Author keywords

BNP; Cardiomyopathy; GIK infusion; Systolic functions

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLUCOSE; INSULIN; POTASSIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; LONG TERM CARE; MALE; PROTEIN BLOOD LEVEL; REPEATED DRUG DOSE; SYSTOLIC HEART FAILURE;

EID: 45749113759     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. McNulty PH. Comparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart disease. Am J Physiol Heart Circ Physiol 2000;278:H741-7.
2. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-25.
3. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
4. Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg 2006;131:34-42.
5. Zhu P, Lu L, Xu Y, Greyson C, Schwartz GG. Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 2000;278:H595-603.
6. Castro PF, Larrain G, Baeza R, et al. Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty. Crit Care Med 2003;31:2152-5.
7. Alan S, Ulgen MS, Dedeoglu I, Kaya H, Toprak N. Long-term glucose insulin potassium infusion improves systolic and diastolic function in patients with chronic ischemic cardiomyopathy. Swiss Med Wkly 2003;133:419-22.
8. Haug C, Metzele A, Kochs M, Hombach V, Grünert A. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol 1993;16:553-7.
9. Karabulut A, Kaplan A, Aslan C, Iltumur K, Toprak G, Toprak N. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure. Acta Cardiol 2005;60:631-8.
10. Kirk V, Bay M, Parner J, et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: Data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail 2004;6:335-41.
11. Murdoch DR, McDonagh TA, Byrne J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1999;138:1126-32.
12. Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 2001;19:557-71.
13. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
14. Cottin Y, Lhuillier I, Gilson L, et al. Glucose insulin potassium infusion improves systolic function in patients with chronic ischemic cardiomyopathy. Eur J Heart Fail 2002;4:181-4.
15. Khoury VK, Haluska B, Prins J, Marwick TH. Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction. Heart 2003;89:61-5.
16. Schinkel AF, Bax JJ, van Dornburg R, et al. Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy. J Nucl Med 2003;44:127-33.
17. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.
18. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 1. Circulation 2001;104:2981-9.
19. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 2. Circulation 2001;104:3158-67.
20. Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg 1999;68:1898-904.
21. Schofield RS, Hill JA. Role of metabolically active drugs in the management of ischemic heart disease. Am J Cardiovasc Drugs 2001;1:23-35.
22. Angelos MG, Murray HN, Gorsline RT, Klawitter PF. Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics. Resuscitation 2002;55:329-36.
23. Xu KY, Zweier JL, Becker LC. Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. Circ Res 1995;77:88-97.
24. Gupta MP, Lee SL, Dhalla NS. Activation of heart sarcoplasmic reticulum Ca++-stimulated adenosine triphosphatase by insulin. J Pharmacol Exp Ther 1989;249:623-30.
25. Valle R, Prevaldi C, D'Eri A, et al. B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema. Am J Geriatr Cardiol 2006;15:202-7.
26. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-41.
27. Rogers WJ, Stanley AW Jr, Breinig JB, et al. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J 1976;92:441-54.